Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 31.45 is 26% above its 5-year average of 24.98, around the middle of its 5-year range (14.08–60.41).
As of the fiscal period ended Tuesday, June 30, 2026. 47.07% above its 12-month average of 21.39.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 31.45.
QUICK RATIO (ACID-TEST)
31.45
QUICK RATIO (ACID-TEST) AVG TTM
21.39
QUICK RATIO (ACID-TEST) AVG 3Y
32.08
QUICK RATIO (ACID-TEST) AVG 5Y
24.98
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+47.07%
CURRENT VS 3Y AVG
-1.95%
CURRENT VS 5Y AVG
+25.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 635 covered companies
CURRENT VS SECTOR MEDIAN
+951.91%
vs the sector median at left
Climb Bio, Inc.
Market Cap
$636.48M
Quick Ratio (Acid-Test)
31.45
TTM Avg
21.39
3Y Avg
32.08
5Y Avg
24.98
Market Cap
$640.57M
Quick Ratio (Acid-Test)
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$610.07M
Quick Ratio (Acid-Test)
1.49
TTM Avg
1.44
3Y Avg
1.41
5Y Avg
1.41
Market Cap
$665.40M
Quick Ratio (Acid-Test)
4.79
TTM Avg
3.80
3Y Avg
3.38
5Y Avg
3.21
Market Cap
$666.36M
Quick Ratio (Acid-Test)
8.03
TTM Avg
12.16
3Y Avg
13.50
5Y Avg
14.42
Market Cap
$666.95M
Quick Ratio (Acid-Test)
10.97
TTM Avg
8.63
3Y Avg
10.75
5Y Avg
10.66
Market Cap
$600.96M
Quick Ratio (Acid-Test)
6.18
TTM Avg
5.54
3Y Avg
6.26
5Y Avg
5.77
Market Cap
$597.83M
Quick Ratio (Acid-Test)
6.06
TTM Avg
2.91
3Y Avg
9.30
5Y Avg
9.54
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Climb Bio, Inc. (CLYM) | $636.48M | 31.45 | 21.39 | 32.08 | 24.98 |
| Aura Biosciences, Inc. (AURA)vs › | $640.57M | 16.82 | 9.46 | 14.12 | 14.05 |
| OmniAb, Inc. (OABI)vs › | $643.45M | 4.80 | 4.27 | 4.36 | 3.29 |
| AngioDynamics, Inc. (ANGO)vs › | $610.07M | 1.49 | 1.44 | 1.41 | 1.41 |
| MiMedx Group, Inc. (MDXG)vs › | $665.40M | 4.79 | 3.80 | 3.38 | 3.21 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.36M | 8.03 | 12.16 | 13.50 | 14.42 |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 10.97 | 8.63 | 10.75 | 10.66 |
| Fulgent Genetics, Inc. (FLGT)vs › | $600.96M | 6.18 | 5.54 | 6.26 | 5.77 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.83M | 6.06 | 2.91 | 9.30 | 9.54 |
| Annexon, Inc. (ANNX)vs › | $679.13M | 5.53 | 8.02 | 10.47 | 14.43 |
Quick Ratio
31.45
Excludes inventory
Current Ratio
31.45
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 31.45 |
| 2026-03-31 | 27.86 |
| 2025-12-31 | 15.16 |
| 2025-09-30 | 18.38 |
| 2025-06-30 | 14.08 |
| 2025-03-31 | 14.25 |
| 2024-12-31 | 31.41 |
| 2024-09-30 | 57.73 |
| 2024-06-30 | 60.41 |
| 2024-03-31 | 37.02 |
| 2023-12-31 | 38.92 |
| 2023-09-30 | 38.76 |
| 2023-06-30 | 31.58 |
| 2023-03-31 | 24.45 |
| 2022-12-31 | 22.04 |
| 2022-09-30 | 21.21 |
| 2022-06-30 | 17.48 |
| 2022-03-31 | 19.33 |
| 2021-12-31 | 24.58 |
| 2021-09-30 | 28.38 |
| 2021-06-30 | 18.34 |
| 2021-03-31 | 12.91 |
| 2020-12-31 | 7.18 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
